Related references
Note: Only part of the references are listed.Effects of aberrant gamma frequency oscillations on prepulse inhibition
Nigel C. Jones et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Chronic administration of antipsychotics attenuates ongoing and ketamine-induced increases in cortical γ oscillations
Paul M. Anderson et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Antipsychotic compounds differentially modulate high-frequency oscillations in the rat nucleus accumbens: a comparison of first- and second-generation drugs
Maciej Olszewski et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Differential Role of NR2A and NR2B Subunits in N-Methyl-D-Aspartate Receptor Antagonist-Induced Aberrant Cortical Gamma Oscillations
Bernat Kocsis
BIOLOGICAL PSYCHIATRY (2012)
Opposite effects of ketamine and deep brain stimulation on rat thalamocortical information processing
Sofya P. Kulikova et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2012)
Acute administration of typical and atypical antipsychotics reduces EEG gamma power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in gamma power
Nigel C. Jones et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Early Cognitive Experience Prevents Adult Deficits in a Neurodevelopmental Schizophrenia Model
Heekyung Lee et al.
NEURON (2012)
Gamma synchrony: Towards a translational biomarker for the treatment-resistant symptoms of schizophrenia
Michael J. Gandal et al.
NEUROPHARMACOLOGY (2012)
From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
Bita Moghaddam et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Reduced Early Auditory Evoked Gamma-Band Response in Patients with Schizophrenia
Gregor Leicht et al.
BIOLOGICAL PSYCHIATRY (2010)
Abnormal neural oscillations and synchrony in schizophrenia
Peter J. Uhlhaas et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Gamma and Delta Neural Oscillations and Association with Clinical Symptoms under Subanesthetic Ketamine
L. Elliot Hong et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism
Joanna C. Neill et al.
PHARMACOLOGY & THERAPEUTICS (2010)
d-Serine and a glycine transporter-1 inhibitor enhance social memory in rats
Toshiharu Shimazaki et al.
PSYCHOPHARMACOLOGY (2010)
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Stefan Leucht et al.
LANCET (2009)
N-METHYL-D-ASPARTIC ACID RECEPTOR ANTAGONIST-INDUCED FREQUENCY OSCILLATIONS IN MICE RECREATE PATTERN OF ELECTROPHYSIOLOGICAL DEFICITS IN SCHIZOPHRENIA
R. S. Ehrlichman et al.
NEUROSCIENCE (2009)
NMDA Receptor Hypofunction Leads to Generalized and Persistent Aberrant γ Oscillations Independent of Hyperlocomotion and the State of Consciousness
Tahir Hakami et al.
PLOS ONE (2009)
D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats
Jun-Ichi Karasawa et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Abnormal neural oscillatory activity to speech sounds in schizophrenia: A magnetoencephalography study
Shogo Hirano et al.
JOURNAL OF NEUROSCIENCE (2008)
Cortical source estimates of gamma band amplitude and phase are different in schizophrenia
Peter Teale et al.
NEUROIMAGE (2008)
Glycine and D-serine, but not D-cycloserine, attenuate prepulse inhibition deficits induced by NMDA receptor antagonist MK-801
Nobuhisa Kanahara et al.
PSYCHOPHARMACOLOGY (2008)
Event-related EEG time-frequency analysis: An overview of measures and an analysis of early gamma band phase locking in schizophrenia
Brian J. Roach et al.
SCHIZOPHRENIA BULLETIN (2008)
Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients
Gregory A. Light et al.
BIOLOGICAL PSYCHIATRY (2006)
Effects of the mGluR2/3 agonist LY379268 on ketamine-evoked behaviours and neurochemical changes in the dentate gyrus of the rat
Gabor Imre et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2006)
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment
JP McEvoy et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating
V Bubeníková et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia
ND Woodward et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
Cognitive functions of gamma-band activity: memory match and utilization
CS Herrmann et al.
TRENDS IN COGNITIVE SCIENCES (2004)
Cognitive deficits as treatment targets in schizophrenia
JM Gold
SCHIZOPHRENIA RESEARCH (2004)
Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia
I Bitter et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
Hallucinations:: Synchronisation of thalamocortical γ oscillations underconstrained by sensory input
RP Behrendt
CONSCIOUSNESS AND COGNITION (2003)
Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: Modulation by a group II selective metabotropic glutamate receptor agonist LY379268
DS Lorrain et al.
NEUROSCIENCE (2003)
Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: Reversal by clozapine, olanzapine and risperidone but not by haloperidol
G Le Pen et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Improvement of cognitive dysfunction after treatment with second-generation antipsychotics
E Weiss et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder
RM Bilder et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
An integration of 40 Hz Gamma and phasic arousal: novelty and routinization processing in schizophrenia
KH Lee et al.
CLINICAL NEUROPHYSIOLOGY (2001)
Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies
DL Braff et al.
PSYCHOPHARMACOLOGY (2001)
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review
MA Geyer et al.
PSYCHOPHARMACOLOGY (2001)
Share Paper
